BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mansur SA, Mieczkowska A, Flatt PR, Chappard D, Irwin N, Mabilleau G. The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice. Front Endocrinol (Lausanne) 2019;10:51. [PMID: 30809192 DOI: 10.3389/fendo.2019.00051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Nirwan N, Vohora D. Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice. Front Endocrinol 2022;13:944323. [DOI: 10.3389/fendo.2022.944323] [Reference Citation Analysis]
2 Zhang Z, Zhang Z, Pei L, Zhang X, Li B, Meng Y, Zhou X. How high-fat diet affects bone in mice: A systematic review and meta-analysis. Obes Rev 2022;:e13493. [PMID: 35822276 DOI: 10.1111/obr.13493] [Reference Citation Analysis]
3 Shi S, Song S, Liu X, Zhao G, Ding F, Zhao W, Zhang S, Song Y, Ma W. Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats. Drug Deliv 2022;29:548-60. [PMID: 35156499 DOI: 10.1080/10717544.2022.2036873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mieczkowska A, Bouvard B, Legrand E, Mabilleau G. [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures. Front Endocrinol (Lausanne) 2021;12:721506. [PMID: 34421828 DOI: 10.3389/fendo.2021.721506] [Reference Citation Analysis]
5 Heinla K, Vasar E, Sedman T, Volke V. A GLP-1 Receptor Agonist Inhibits Aldosterone Release in Healthy Volunteers. Horm Metab Res 2021;53:402-7. [PMID: 34154031 DOI: 10.1055/a-1498-7098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kitaura H, Ogawa S, Ohori F, Noguchi T, Marahleh A, Nara Y, Pramusita A, Kinjo R, Ma J, Kanou K, Mizoguchi I. Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption. Int J Mol Sci 2021;22:6578. [PMID: 34205264 DOI: 10.3390/ijms22126578] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Lafferty RA, O'Harte FPM, Irwin N, Gault VA, Flatt PR. Proglucagon-Derived Peptides as Therapeutics. Front Endocrinol (Lausanne) 2021;12:689678. [PMID: 34093449 DOI: 10.3389/fendo.2021.689678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Donat A, Knapstein PR, Jiang S, Baranowsky A, Ballhause TM, Frosch KH, Keller J. Glucose Metabolism in Osteoblasts in Healthy and Pathophysiological Conditions. Int J Mol Sci 2021;22:4120. [PMID: 33923498 DOI: 10.3390/ijms22084120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Tanday N, Flatt PR, Irwin N. Metabolic responses and benefits of glucagon-like peptide-1 (GLP-1) receptor ligands. Br J Pharmacol 2021. [PMID: 33822370 DOI: 10.1111/bph.15485] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Shen WR, Kitaura H, Qi J, Ogawa S, Ohori F, Noguchi T, Marahleh A, Nara Y, Adya P, Mizoguchi I. Local administration of high-dose diabetes medicine exendin-4 inhibits orthodontic tooth movement in mice. Angle Orthod 2021;91:111-8. [PMID: 33289799 DOI: 10.2319/021320-103.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Qiao J, Wu Y, Ren Y. The impact of a high fat diet on bones: potential mechanisms. Food Funct 2021;12:963-75. [DOI: 10.1039/d0fo02664f] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mabilleau G, Bouvard B. Update on: effects of anti-diabetic drugs on bone metabolism. Expert Rev Endocrinol Metab 2020;15:415-30. [PMID: 33059497 DOI: 10.1080/17446651.2020.1831911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Li Y, Fu H, Wang H, Luo S, Wang L, Chen J, Lu H. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway. Molecular and Cellular Endocrinology 2020;515:110921. [DOI: 10.1016/j.mce.2020.110921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mieczkowska A, Millar P, Chappard D, Gault VA, Mabilleau G. Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model. Calcif Tissue Int 2020;107:281-93. [PMID: 32642787 DOI: 10.1007/s00223-020-00720-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Vyavahare SS, Mieczkowska A, Flatt PR, Chappard D, Irwin N, Mabilleau G. GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice. Peptides 2020;125:170207. [DOI: 10.1016/j.peptides.2019.170207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
16 Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Glucagon-like peptide 1 (GLP-1). Mol Metab 2019;30:72-130. [PMID: 31767182 DOI: 10.1016/j.molmet.2019.09.010] [Cited by in Crossref: 212] [Cited by in F6Publishing: 204] [Article Influence: 70.7] [Reference Citation Analysis]